Functional and phenotypic assessment of the IPS/FVS-specific CD8+ T cells indicated their capacity to reduce low concentrations of SARS-CoV-2 in vitro, but these cross-reactive T cells detected in two severe COVID-19 patients were not activated based on phenotypic characterization. The gene discussed is CD8A; the disease is COVID-19.